Toward a Combination of Biomarkers for Molecular Characterization of Multiple Sclerosis

Toward a Combination of Biomarkers for Molecular Characterization of Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system associated with chronic inflammation, demyelination, and axonal damage. MS is a highly heterogeneous disease that leads to discrepancies regarding the clinical appearance, progression, and therapy response of patie...

Full description

Bibliographic Details
Main Authors:	Dafni Birmpili, Imane Charmarke Askar, Lucas Dinh Pham-Van, Thomas Kuntzel, Caroline Spenlé, Aurélien Riou, Dominique Bagnard
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	International Journal of Molecular Sciences
Subjects:	multiple sclerosis biomarkers experimental autoimmune encephalomyelitis RNA
Online Access:	https://www.mdpi.com/1422-0067/23/22/14000

Similar Items

The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
by: Dafni Birmpili, et al.
Published: (2022-09-01)

Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform Oligomerisation
by: Thomas Kuntzel, et al.
Published: (2023-05-01)

Multiple sclerosis and exercise—A disease-modifying intervention of mice or men?
by: Sarah-Jane Martin, et al.
Published: (2023-10-01)

The Anti-inflammatory Effect of Ginger Extract on the Animal Model of Multiple Sclerosis
by: Fatemeh Kamankesh, et al.
Published: (2023-06-01)

Nature plus Nurture*: the triggering of multiple sclerosis
by: Hartmut Wekerle
Published: (2015-09-01)

Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis
by: Petra Hundehege, et al.
Published: (2018-11-01)

The Role of Selected Interleukins in the Development and Progression of Multiple Sclerosis—A Systematic Review
by: Cezary Grunwald, et al.
Published: (2024-02-01)

Allopregnanolone and Neuroinflammation: a Focus on Multiple Sclerosis
by: Farshid eNoorbakhsh, et al.
Published: (2014-06-01)

A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis
by: Euan R. O. Allan, et al.
Published: (2017-05-01)

Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels
by: Gareth Pryce, et al.
Published: (2023-07-01)

Curcumin ameliorates oxidative stress in animal models of multiple sclerosis
by: Laleh Mavaddatiyan, et al.
Published: (2019-04-01)

Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis
by: Polak Paul E, et al.
Published: (2012-12-01)

Effects of Quercetin on Improving the Damage Caused by Free Radicals in the Rat Models of Multiple Sclerosis
by: Elina Mirzazadeh, et al.
Published: (2019-04-01)

The Role of MicroRNAs in Repair Processes in Multiple Sclerosis
by: Conor P. Duffy, et al.
Published: (2020-07-01)

Effect of Cordyceps sinensis on the Treatment of Experimental Autoimmune Encephalomyelitis: A Pilot Study on Mice Model
by: Shan-Shan Zhong, et al.
Published: (2017-01-01)

The Effects of Nicotine on the Stimulation of the Cholinergic System and Immune Responses Changes in Animal Models of Multiple Sclerosis
by: M Shahmoradi, et al.
Published: (2016-06-01)

Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis
by: Lisa Thiele née Schrewe, et al.
Published: (2020-01-01)

Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
by: Jordan R. Warford, et al.
Published: (2018-01-01)

Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
by: Juliana Helena dos Santos de Toledo, et al.
Published: (2020-10-01)

B cells in multiple sclerosis
by: Hartmut Wekerle
Published: (2017-01-01)

The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology
by: Roberta Amoriello, et al.
Published: (2024-01-01)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
by: Sofia P. das Neves, et al.
Published: (2018-10-01)

Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
by: Alessandra Musella, et al.
Published: (2018-08-01)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
by: Marina Boziki, et al.
Published: (2023-01-01)

RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis
by: Alba Manresa-Arraut, et al.
Published: (2018-05-01)

Editorial: Diet and multiple sclerosis
by: Tyler J. Titcomb, et al.
Published: (2023-12-01)

What Guides Peripheral Immune Cells into the Central Nervous System?
by: Theresa Greiner, et al.
Published: (2021-08-01)

Effect of Voluntary Training after the Induction of Experimental Autoimmune Encephalomyelitis on Some Myelin-Producing Proteins in Female C57BL/6 Mice
by: Yasaman Honarmandnasab, et al.
Published: (2021-02-01)

Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy
by: Jacqueline M. Orian, et al.
Published: (2021-02-01)

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells
by: Maryam J. Tavaf, et al.
Published: (2023-01-01)

Osteopontin expression and the effect of anti-VLA-4 mAb treatment in experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis
by: Grażyna Pyka-Fościak, et al.
Published: (2023-07-01)

Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis
by: Ettore Dolcetti, et al.
Published: (2020-10-01)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
by: Amy Lovett-Racke, et al.
Published: (2022-11-01)

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
by: Trevor O. Kirby, et al.
Published: (2018-08-01)

Complete Freund’s adjuvant as a confounding factor in multiple sclerosis research
by: Milica Lazarević, et al.
Published: (2024-02-01)

Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis
by: Alejandro Torrillas-de la Cal, et al.
Published: (2023-09-01)

The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis
by: Gregory F. Wu, et al.
Published: (2023-04-01)

Effects of cigarette smoke exposure on a mouse model of multiple sclerosis
by: Jenny Ho, et al.
Published: (2022-01-01)

Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis
by: Jacqueline A. Quandt, et al.
Published: (2019-08-01)

Blockade of Experimental Multiple Sclerosis by Inhibition of the Acid Sphingomyelinase/Ceramide System
by: Katrin Anne Becker, et al.
Published: (2017-11-01)